Aspyra not in NYSE compliance
Aspyra (Westlake Village, California), a provider of clinical and diagnostic information systems for the healthcare industry, said it has received notice from NYSE Amex that it does not meet one of the exchange's continued listing standards. The notice reports that Aspyra is not in compliance with Section 1003(a)(iv) of the company guide. The company can submit a plan of compliance to the exchange by Oct. 26, addressing how it intends to regain compliance with Section 1003(a)(iv) of the company guide by March 24.
TCP Innovations opens U.S. office
TCP Innovations (Cambridge, UK), a life sciences consultancy and seed investment fund, reported the opening of its first office in the U.S. The company has named Robert Schroff as a Principal Consultant, who will lead a growing team of U.S. consultants, closely integrated with the existing European group, to perform consulting projects for U.S. clients. The US operation will be managed through the new office in Seattle, Washington.
Founded in 2001, TCP Innovations covers therapeutics, diagnostics, medical devices and healthcare technology. It has also been responsible for founding half a dozen new life sciences businesses, including the rapidly growing contract research organization, Total Scientific, based on the Babraham science park and Funxional Therapeutics, a clinical-stage therapeutics company with exciting anti-inflammatory products in development, which has offices in central Cambridge.
Edwards Lifesciences to open new Utah facility
Edwards Lifesciences (Irvine, California), a specialist in the science of heart valves and hemodynamic monitoring, said that in anticipation of future growth, will be developing a new manufacturing facility in Draper, Utah.
"Our new facility will allow us to evolve our world class operations to support Edwards' long-term global product supply strategy," said Paul Redmond, Edwards' corporate VP, Global Corporate Operations. "We are very grateful to the Governor's Office of Economic Development in Utah and the Draper City Council for their extraordinary efforts in working with us to ensure our success in creating a stronger and more customer-focused company, poised for even more growth in the future."
Edwards has accepted incentives from the State of Utah totaling approximately $11.5 million based on the current 228 jobs being retained and more than 1,000 projected new jobs in manufacturing, business and engineering expected to be created in the state during the life of the 15-year incentive period. The company also accepted an incentive from the City of Draper for approximately $3 million based on capital investments and employment rates over a seven-year incentive period.
Claros Diagnostics receives certifications
Claros Diagnostics (Woburn, Massachusetts), a developer of novel point-of-care immunoassay systems, reported the receipt of corporate ISO 13485 and CMDCAS certificates of registration issued by the National Standards Authority of Ireland (NSAI). ISO 13485 is an internationally recognized standard which defines the requirements for design, development, production, and distribution of medical devices.